Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cδ elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA

Molecular and Cellular Biology

Volumn 28, Issue 8, 2008, Pages 2608-2625

  Doller, Anke ^a   Akool, El Sayed ^a   Huwiler, Andrea ^a,b   Müller, Roswitha ^a   Radeke, Heinfried H ^a   Pfeilschifter, Josef ^a   Eberhardt, Wolfgang ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYCLOOXYGENASE 2; CYTOKINE; DACTINOMYCIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HUR PROTEIN; MESSENGER RNA; PROTEIN KINASE C DELTA; SERINE;

3' UNTRANSLATED REGION; ARTICLE; CYTOPLASM; CYTOSKELETON; ENZYME REGULATION; ENZYME STABILITY; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MESANGIUM CELL; NUCLEAR EXPORT SIGNAL; NUCLEOTIDE SEQUENCE; POLYSOME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; RNA INTERFERENCE; RNA STABILITY;

ACTIVE TRANSPORT, CELL NUCLEUS; ANGIOTENSIN II; ANTIGENS, SURFACE; BASE SEQUENCE; BINDING SITES; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; CYTOPLASM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-DELTA; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 42149150455     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01530-07     Document Type: Article

References (64)

1. Abdelmohsen, K., R. Pullmann, Jr., A. Lal, H. H. Kim, S. Galban, X. Yang, J. D. Blethrow, M. Walker, J. Shubert, D. A. Gillespie, H. Furneaux, and M. Gorospe. 2007. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 25:543-557.
2. Antic, D., and J. D. Keene. 1998. Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus. J. Cell Sci. 111:183-197.
3. Aschrafi, A., S. Shabahang, J. Pfeilschifter, and A. Huwiler. 2003. Regulatory functions of protein kinase C isoenzymes in the kidney. Curr. Topics Biochem. Res. 5:27-41.
4. Chandrasekharan, N. V., and D. L. Simmons. 2004. The cyclooxygenases. Genome Biol. 5:241.
5. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
6. Cok, S. J., S. J. Acton, and A. R. Morrison. 2003. The proximal region of the 3′-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J. Biol. Chem. 278:36157-36162.
7. Dean, J. L. E., R. Wait, K. R. Mahtani, G. Sully, A. R. Clark, and J. Saklatvala. 2001. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21:721-730.
8. Dixon, D. A., C. D. Kaplan, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2000. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem. 275:11750-11757.
9. Dixon, D. A., N. D. Tolley, P. H. King, L. B. Nabors, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2001. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Investig. 108:1657-1665.
10. Doller, A., A. Huwiler, R. Muller, H. H. Radeke, J. Pfeilschifter, and W. Eberhardt. 2007. Protein kinase Cα-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol. Biol. Cell 18:2137-2148.
11. Eberhardt, W., M. Schulze, C. Engels, E. Klasmeier, and J. Pfeilschifter. 2002. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-κB and Ets transcription factors. Mol. Endocrinol. 16:1752-1766.
12. Eberhardt, W., A. Doller, A. E.-S. Akool, and J. Pfeilschifter. 2007. Modulation of mRNA stability as a novel therapeutic approach. Pharmacol. Ther. 114:56-73.
13. Erkinheimo, T. L., H. Lassus, A. Sivula, S. Sengupta, H. Furneaux, T. Hla, C. Haglund, R. Butzow, and A. Ristimaki. 2003. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res. 63:7591-7594.
14. Fan, X. C., and J. A. Steitz. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448-3460.
15. 2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human svnovial fibroblasts. J. Biol. Chem. 276:31720-31731.
16. Geiges, D., T. Meyer, B. Marte, M. Vanek, G. Weissgerber, S. Stabel, J. Pfeilschifter, D. Fabbro, and A. Huwiler. 1997. Activation of protein kinase C subtypes α, γ, δ, ε, ζ, and η by tumor-promoting and nontumor-promoting agents. Biochem. Pharmacol. 53:865-875.
17. Grall, F. T., W. C. Prall, W. Wei, X. Gu, J. Y. Cho, B. K. Choy, L. F. Zerbini, M. S. Inan, S. R. Goldring, E. M. Gravallese, M. B. Goldring, P. Oettgen, and T. A. Libermann. 2005. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J. 272:1676-1687.
18. Guhaniyogi, J., and G. Brewer. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
19. Hovland, R., G. Campbell, I. Pryme, and J. Hesketh. 1995. The mRNAs for cyclin A, c-myc and ribosomal proteins L4 and S6 are associated with cytoskeletal-bound polysomes in HepG2 cells. Biochem. J. 310:193-196.
20. Idris, I., S. Gray, and R. Donnelly. 2001. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44:659-673.
21. Inoguchi, T., T. Sonta, H. Tsubouchi, T. Etoh, M. Kakimoto, N. Sonoda, N. Sato, N. Sekiguchi, K. Kobayashi, H. Sumimoto, H. Utsumi, and H. Nawata. 2003. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J. Am. Soc. Nephrol. 14:227-232.
22. Jaimes, E. A., R. X. Tian, D. Pearse, and L. Raij. 2005. Up-regulation of glomerular COX-2 by angiotensin II: role of reactive oxygen species. Kidney Int. 68:2143-2153.
23. Jaken, S., and P. J. Parker. 2000. Protein kinase C binding partners. Bioessays 22:245-254.
24. Jobin, C., O. Morteau, D. S. Han, and R. Balfour Sartor. 1998. Specific NF-κB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 95:537-543.
25. Jones, D. A., D. P. Carlton, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1993. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268:9049-9054.
26. Keene, J. D. 1999. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 96:5-7.
27. Kirtikara, K., R. Raghow, S. J. Laulederkind, S. Goorha, T. Kanekura, and L. R. Ballou. 2000. Transcriptional regulation of cyclooxygenase-2 in the human microvascular endothelial cell line, HMEC-1: control by the combinatorial actions of AP2, NF-IL-6 and CRE elements. Mol. Cell. Biochem. 203:41-51.
28. Kujubu, D. A., B. S. Fletcher, B. C. Varnum, R. W. Lim, and H. R. Herschman. 1991. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:12866-12872.
29. -ΔΔCT method. Methods 25:402-408.
30. Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:8144-8151.
31. Maloney, J. A., O. Tsygankova, A. Szot, L. Yang, Q. Li, and J. R. Williamson. 1998. Differential translocation of protein kinase C isozymes by phorbol esters, EGF, and ANGII in rat liver WB cells. Am. J. Physiol. 274:C974-C982.
32. Meade, E. A., T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1999. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem. 274:8328-8334.
33. Ming, X.-F., G. Stoecklin, M. Lu, R. Looser, and C. Moroni. 2001. Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol. Cell. Biol. 21:5778-5789.
34. Misquitta, C. M., V. R. Iyer, E. S. Werstiuk, and A. K. Grover. 2001. The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology. Mol. Cell. Biochem. 224:53-67.
35. Mitchell, J. A., and T. D. Warner. 2006. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat. Rev. Drug Discov. 5:75-86.
36. Mrena, J., J. P. Wiksten, A. Thiel, A. Kokkola, L. Pohjola, J. Lundin, S. Nordling, A. Ristimaki, and C. Haglund. 2005. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin. Cancer Res. 11:7362-7368.
37. Niranjanakumari, S., E. Lasda, R. Brazas, and M. A. Garcia-Blanco. 2002. Reversible cross-linking combined with IP to study RNA-protein interactions in vivo. Methods 26:182-190.
38. Pascale, A., M. Amadio, G. Scapagnini, C. Lanni, M. Racchi, A. Provenzani, S. Govoni, D. L. Alkon, and A. Quattrone. 2005. Neuronal ELAV proteins enhance mRNA stability by a PKCα-dependent pathway. Proc. Natl. Acad. Sci. USA 102:12065-12070.
39. Peng, S. S., C. Y. Chen, N. Xu, and A. B. Shyu. 1998. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17:3461-3470.
40. Pfeilschifter, J., and H. Muhl. 1990. Interleukin 1 and tumor necrosis factor potentiate angiotensin II- and calcium ionophore-stimulated prostaglandin E2 synthesis in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 169:585-595.
41. Pfeilschifter, J., C. Schalkwijk, V. A. Briner, and H. van den Bosch. 1993. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J. Clin. Investig. 92:2516-2523.
42. Pfeilschifter, J., and A. Huwiler. 1996. Regulatory functions of protein kinase C isoenzymes in purinoceptor signalling in mesangial cells. J. Auton. Pharmacol. 16:315-318.
43. Radeke, H. H., B. Meier, N. Topley, J. Floge, G. G. Habermehl, and K. Resch. 1990. Interleukin 1-β and tumor necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int. 37:767-775.
44. Ristimaki, A., K. Narko, and T. Hla. 1996. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem. J. 318:325-331.
45. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
46. Sengupta, S., B. C. Jang, M. T. Wu, J. H. Paik, H. Furneaux, and T. Hla. 2003. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J. Biol. Chem. 278:25227-25233.
47. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
48. Sheng, H., J. Shao, D. A. Dixon, C. S. Williams, S. M. Prescott, R. N. DuBois, and R. D. Beauchamp. 2000. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275:6628-6635.
49. Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145-182.
50. Sorli, C. H., H. J. Zhang, M. B. Armstrong, R. V. Rajotte, J. Maclouf, and R. P. Robertson. 1998. Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc. Natl. Acad. Sci. USA 95:1788-1793.
51. Srivastava, S. K., T. Tetsuka, D. Daphna-Iken, and A. R. Morrison. 1994. IL-1β stabilizes COX II mRNA in renal mesangial cells: role of 3′-untranslated region. Am. J. Physiol. 267:F504-F508.
52. Steinberg, S. F. 2004. Distinctive activation mechanisms and functions for protein kinase C8. Biochem. J. 384:449-459.
53. Subbaramaiah, K., T. P. Marmo, D. A. Dixon, and A. J. Dannenberg. 2003. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J. Biol. Chem. 278:37637-37647.
54. Wang, W., J. Fan, J. X. Yang, S. Fürer-Galban, I. Lopez de Silanes, C. von Kobbe, J. Guo, S. N. Georas, F. Foufelle, D. G. Hardie, D. Carling, and M. Gorospe. 2002. AMP-activated kinase regulates cytoplasmic HuR. Mol. Cell. Biol. 22:3425-3436.
55. Warner, T. D., and J. A. Mitchell. 2004. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18:790-804.
56. Whiteside, C. I., and J. A. Dlugosz. 2002. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am. J. Physiol. Renal Physiol. 282:F975-F980.
57. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:4969-4980.
58. Winzen, R., G. Gowrishankar, F. Bollig, N. Redich, K. Resch, and H. Holtmann. 2004. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol. Cell. Biol. 24:4835-4847.
59. Xie, W. L., J. G. Chipman, D. L. Robertson, R. L. Erikson, and D. L. Simmons. 1991. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA 88:2692-2696.
60. Xu, N., C.-Y. A. Chen, and A.-B. Shyu. 2001. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol. Cell. Biol. 21:6960-6971.
61. Yao, K. M., M. L. Samson, R. Reeves, and K. White. 1993. Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J. Neurobiol. 24:723-739.
62. Yoshida, K., Y. Miki, and D. Kufe. 2002. Activation of SAPK/JNK signaling by protein kinase Cδ in response to DNA damage. J. Biol. Chem. 277:48372-48378.
63. Yu, C., R. Gong, A. Rifai, E. M. Tolbert, and L. D. Dworkin. 2007. Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection. J. Am. Soc. Nephrol. 18:750-759.
64. Zalfa, F., B. Eleuteri, K. S. Dickson, V. Mercaldo, S. De Rubeis, A. di Penta, E. Tabolacci, P. Chiurazzi, G. Neri, S. G. Grant, and C. Bagni. 2007. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat. Neurosci. 10:578-587.